CFML539A12101 A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu] Lu-DWJ155 and safety and imaging properties of [68Ga] Ga-DWJ155 in patients with solid tumors

  • Phase I
  • Trial Category: Other Solid Tumor

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*